HCPCS Level II drug code
Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
In short
Q9961 is the HCPCS Level II code for high osmolar contrast material, 250-299 mg/ml iodine concentration, per ml. CMS assigns NDCs for Conray to it. The Medicare Part B payment limit is $0.205 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Short descriptor
- Hocm 250-299mg/ml iodine,1ml
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jul 1, 2005
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under Q9961
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to Q9961 for Conray. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Conray | 00019-0953-05 | Liebel-Flarsheim Company LLC | 25 × 50 | 1,250 |
Q9961: common questions
- Is Q9961 a CPT code?
- No. Q9961 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under Q9961?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under Q9961, for Conray. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for Q9961?
- $0.205 per 1 ml, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.